Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Henryschein Dental Company (NQ: HSIC )

76.00 -1.62 (-2.09%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Henryschein Dental Company

< Previous 1 2 3 4 Next >
This Analog Devices Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
3 Reasons HSIC is Risky and 1 Stock to Buy Instead
Henry Schein has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 13.3% to $77.62 per share while the index has gained... 
Via StockStory
Topics Stocks
Exposures US Equities
What Analysts Are Saying About Henry Schein Stock
Via Benzinga
In today's session, there are S&P500 stocks with remarkable trading volume.
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Wednesday. Stay informed about the market activity below. 
Via Chartmill
Wednesday's session: top gainers and losers in the S&P500 index
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Wednesday. 
Via Chartmill
How Is The Market Feeling About Henry Schein?
Via Benzinga
The Analyst Verdict: Henry Schein In The Eyes Of 4 Experts
Via Benzinga
KKR Sinks Its Teeth Into Henry Schein With Additional Investment And Board Seats: Details
Henry Schein shares up on strategic investment from KKR, management appointments, share buyback, and preliminary results. 
Via Benzinga
KKR To Become 12% Shareholder In Henry Schein With Additional $250M Investment: Retail Cheers The Deal
The private equity firm will also be able to purchase additional shares via open market purchases, up to a total equity stake of 14.9% in Henry Schein. 
Via Stocktwits
3 Value Stocks Amid “Unsustainable” Market Euphoria
Three value stocks that are well positioned to outperform in this overvalued market. 
Via Talk Markets
Topics Stocks / Equities
Headline Risks Affecting Healthcare Tech & Distribution Sector Will Likely Continue in 2025: BofA Analyst
BofA sees 2025 challenges for healthcare tech and distributors but upgrades Cardinal Health and Henry Schein, highlighting growth and recovery potential. 
Via Benzinga
Tesla To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Peering Into Henry Schein's Recent Short Interest
Via Benzinga
Analyst Ratings For Henry Schein
Via Benzinga
Where Henry Schein Stands With Analysts
Via Benzinga
What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?
Patient Square Capital agrees to buy Patterson Companies for $4.1 billion. Analysts predict minimal regulatory hurdles and a strong bid unlikely to face competition. 
Via Benzinga
Henry Schein Q3 Earnings: Sees Recovery From Cyber Incident, Says Dental Equipment Business Shows Stability In North America
Henry Schein posts Q3 adjusted EPS of $1.23, topping forecasts, while sales of $3.17 billion fall short. The company revises full-year EPS guidance upwards. 
Via Benzinga
Forecasting The Future: 5 Analyst Projections For Henry Schein
Via Benzinga
HSIC Stock Earnings: Henry Schein Meets EPS, Misses Revenue for Q2 2024
HSIC stock results show that Henry Schein met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Dental Equipment Distributor Henry Schein Reports Mixed Q2 Earnings, Cuts Guidance And Warns Slower Recovery From Cyberattack
Henry Schein Q2 adjusted EPS fell 6.1% to $1.23, beating the $1.22 consensus. Sales grew 1% to $3.10 billion, missing the $3.27B forecast. The company announced a restructuring plan for $75-$100... 
Via Benzinga
Analyst Expectations For Henry Schein's Future
Via Benzinga
Breaking Down Henry Schein: 4 Analysts Share Their Views
Via Benzinga
NASDAQ:HSIC: good value for what you're paying.
HENRY SCHEIN INC (NASDAQ:HSIC) appears to be flying under the radar despite its strong fundamentals. 
Via Chartmill
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
You’ve Been Warned! 3 S&P 500 Stocks to Buy Now or Regret Forever.
The Magnificent Seven aren't the only game in town. These less discovered S&P 500 stocks to buy will deliver tremendous results going forward. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Looking Into Henry Schein's Recent Short Interest
Via Benzinga
Peering Into Henry Schein's Recent Short Interest
Via Benzinga
Looking Into Henry Schein's Recent Short Interest
Via Benzinga
Expert Outlook: Henry Schein Through The Eyes Of 7 Analysts
Via Benzinga
Dental Supplies Distributor Henry Schein's Tech Segment Provides Some Stability In Challenging Macro Times: Analyst
Henry Schein reports Q1 adjusted EPS at $1.10, down 9% Y/Y, with sales at $3.17 billion, up 3.7%. Guidance projects 2024 sales growth at 8%-10%, reaffirming adjusted EPS guidance of $5.00-$5.16.... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.